Glenn Greenberg
Brave Warrior Advisors
Brave Warrior Advisors Portfolio 13F
Glenn Greenberg Holdings Activity
- Portfolio value:
- $2.16B≈
- # of changes:
- 11
- New positions:
- 11
- Reported for:
- 30 Jun 2013 (Q2)
- Latest filing date:
- 14 Aug 2013
Brave Warrior Advisors has disclosed a total of 11 changes to the portfolio in the (2013 Q2) SEC report(s): bought 11 totally new position(s).
What stocks did Glenn Greenberg buy in 2013 Q2?
During 2013 Q2 Glenn Greenberg has bought 11 securities out of which top 5 purchases (by % change to portfolio) were (VRX) Valeant Pharmaceuticals International Inc (new buy), (VPRT) VISTAPRINT NV ORD SHS (NL) (new buy), (ESRX) Express Scripts Holding Co (new buy), (SCHW) Charles Schwab Corp (new buy) and (ORCL) Oracle Corp (new buy).
What did Glenn Greenberg invest in during 2013 Q2?
In the 2013 Q2 report(s) the following changes have been made to the top investments: (VRX) Valeant Pharmaceuticals International Inc (new buy), (VPRT) VISTAPRINT NV ORD SHS (NL) (new buy), (ESRX) Express Scripts Holding Co (new buy), (SCHW) Charles Schwab Corp (new buy) and (ORCL) Oracle Corp (new buy).
11 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
COMCAST CORP-SPECIAL, CL-A
|
new or own*
|
$39.67
|
|
5.07%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Express Scripts Holding Co
|
new or own*
|
$61.74
|
|
11.99%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Fiserv, Inc
|
new or own*
|
$21.85
|
+146.70%($53.91)
|
4.54%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Alphabet Inc, CL-A
|
new or own*
|
$22.01
|
+1,391.45%($328.26)
|
3.14%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Halliburton Company
|
new or own*
|
$41.72
|
-23.75%($31.81)
|
8.49%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
HIGHER ONE HOLDINGS INC
|
new or own*
|
$11.64
|
|
3.41%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Oracle Corp
|
new or own*
|
$30.71
|
+279.68%($116.60)
|
8.70%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Primerica Inc
|
new or own*
|
$37.44
|
+756.25%($320.58)
|
5.78%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Charles Schwab Corp
|
new or own*
|
$21.23
|
+396.23%($105.35)
|
9.20%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
new or own*
|
$86.08
|
|
26.53%
|
2013 Q2 or earlier
|
≈ 0.25+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.